Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Martin+Reck%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Martin+Reck%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Martin+Reck%22&type=Person&sort=year
PubPharm (31)
1
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial
in:
Journal for ImmunoTherapy of Cancer
| 2024
von
Enriqueta Felip
|
David P. Carbone
|
Martin Reck
| +23
Wird geladen...
2
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry
in:
JTO Clinical and Research Reports
| 2023
von
Giannis Mountzios, M.
|
David Planchard, M.
|
Giulio Metro, M.
| +36
Wird geladen...
3
601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC
in:
Journal for ImmunoTherapy of Cancer
| 2023
von
Aditi Qamra
|
Hartmut Koeppen
|
Fabrice Barlesi
| +13
Wird geladen...
4
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
in:
Journal for ImmunoTherapy of Cancer
| 2023
von
Enriqueta Felip
|
Hiroshi Tanaka
|
Silvia Novello
| +18
Wird geladen...
5
Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC.
in:
PLoS ONE
| 2023
von
Virginie Westeel
|
Wolfgang Schuette
|
Thierry Urban
| +4
Wird geladen...
6
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
in:
Journal for ImmunoTherapy of Cancer
| 2022
von
Eugene Kim
|
Federico Cappuzzo
|
Martin Reck
| +11
Wird geladen...
7
Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression
in:
JTO Clinical and Research Reports
| 2022
von
Timothy Rajakumar, M.
|
Rastislav Horos, P.
|
Paul Kittner, B.
| +11
Wird geladen...
8
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects
in:
Journal for ImmunoTherapy of Cancer
| 2022
von
Solange Peters
|
Roy S Herbst
|
Martin Reck
| +1
Wird geladen...
9
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC
in:
JTO Clinical and Research Reports
| 2022
von
Makoto Nishio, M.
|
Kazuto Nishio, M.
|
Martin Reck, M.
| +13
Wird geladen...
10
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials
in:
Journal for ImmunoTherapy of Cancer
| 2022
von
Narikazu Boku
|
Amit Roy
|
Yan Feng
| +12
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
31
Aufsätze
28
E-Artikel
28
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
8
Journal for ImmunoTherapy of Cancer
5
JTO Clinical and Research Reports
2
Cancers
2
Frontiers in Oncology
2
The New England journal of medicine
1
Clinical Medicine Insights: Oncology
1
Clinical and Translational Science
1
EBioMedicine
1
ESMO Open
1
European Respiratory Review
1
Future oncology
1
Journal of Oncology
1
PLoS ONE
1
Respiratory Research
1
Scientific Reports
1
Therapeutic Advances in Medical Oncology
1
npj Precision Oncology
Alle anzeigen ...
weniger ...
Thema
22
Neoplasms. Tumors. Oncology. Including cancer a...
3
Immunotherapy
3
Medicine
3
R
2
Cancer therapies
2
Chemotherapy
2
Diseases of the respiratory system
2
Japan
2
Ligands
2
Lung cancer
2
Metastasis
2
Mutation
2
NSCLC
2
Q
2
Science
1
ALK
1
Algorithms
1
Allografts
1
Alveolar epithelial cells
1
Apoptosis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
24
2020-
7
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
31
Englisch
Haven't found what you're looking for?
Wird geladen...